NHMRC Clinical Trial Centre | Improving Health Outcomes

Trial Login
Trial Data Systems
Donate

×

About Us
Our Work
- - RESEARCH DIVISIONS
  - Cancer
  - Cardiovascular
  - Diabetes
  - Kidney Health
  - Neonatal and Perinatal
  - Health Economics
  - Biostatistics
  - Evidence Integration
  - Translational Research
Our Impact
- Key Breakthroughs
- Trial results
News & Events
- News »
  - Latest news
- Events »
Publications & Funding
Careers
- Working at the CTC »
- Learning with the CTC »
  - Educating the next generation
Patients

Password Recovery

To recover your password please fill in your email address

Email

Back To Login

Don't Have An Account Yet ? Signup!

Create An Account

Please fill in below form to create an account with us

Email

Username

Fullname

Country

Back To Login

Member Login

Email

Password

Remember Me

Forgot Your Password ?

Don't Have An Account Yet ? Signup!

Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for COVID-19 (CLARITY 2.0)

Quick Links

Support Us
Contact Us
Our People

Research Areas

Oncology
Cardiovascular
Diabetes
Neonatal
Health Economics
Biostatistics
Integrating Evidence
Translational research

SPECIALIST AREAS

Independent Data Safety and Monitoring Committee
Randomisation
Labs
Australian New Zealand Clinical Trials Registry
Health Technology Assessment
Genomics Cancer Clinical Trials Initiative

Content coming soon!

NHMRC Clinical Trials Centre at the University of Sydney

ABN 15 211 513 464 CRICOS number: 00026A

+61 2 9562 5000
+61 2 9565 1863
enquiry@ctc.usyd.edu.au

About Us
Our Work
Our Impact
News & Events
Publications & Grants
Careers & Education
FAQ
Contact Us

2019 © NHMRC Clinical Trials Centre at the University of Sydney. All Rights Reserved.

We acknowledge the traditional custodians of the lands on which we work and live, and pay our respects to Elders past, present and future.

Disclaimer Privacy